US EditionInsider Selling: United Therapeutics (NASDAQ:UTHR) Director Sells 50 Shares of Stock
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Insider Selling: Werewolf Therapeutics (NASDAQ:HOWL) Director Sells 37,104 Shares of Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 37,104 shares of the firm’s stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $1.06, for a total value of $39,330.24. Following the sale, the director directly owned 2,935,995 shares of the company’s […]
Luke Evnin Sells 37,104 Shares of Werewolf Therapeutics (NASDAQ:HOWL) Stock
Werewolf Therapeutics, Inc. (NASDAQ:HOWL – Get Free Report) Director Luke Evnin sold 37,104 shares of the firm’s stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $1.06, for a total transaction of $39,330.24. Following the sale, the director owned 2,935,995 shares in the company, valued at $3,112,154.70. […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
